Taming tuberculosis: a challenge for science and society.
Despite scientific advances, we are losing ground against Mycobacterium tuberculosis, a pathogen with which a third of us share our lives. Challenges include fundamental biologic questions; hurdles for translational medicine; and societal deficits in resources, incentives, collaboration, and leadership. Fortunately, the crisis is inspiring scientific and organizational creativity.
Nathan
Carl
C
Department of Microbiology & Immunology, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10065, USA. cnathan@med.cornell.edu
D000995:Antitubercular Agents / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends*; D003140:Communicable Disease Control / Q000379:methods; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000276:immunology* / Q000502:physiology*; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology* / Q000266:history* / Q000517:prevention & control; D014481:United States
D000995:Antitubercular Agents